» Articles » PMID: 29751799

The Aging Lung: Tissue Telomere Shortening in Health and Disease

Abstract

Background: Telomere shortening has been associated with several lung diseases. However, telomere length is generally measured in peripheral blood leucocytes rather than in lung tissue, where disease occurs. Consequently, telomere dynamics have not been established for the normal human lung nor for diseased lung tissue. We hypothesized an age- and disease-dependent shortening of lung tissue telomeres.

Methods: At time of (re-)transplantation or autopsy, 70 explant lungs were collected: from unused donors (normal, n = 13) and patients with cystic fibrosis (CF, n = 12), chronic obstructive pulmonary disease (COPD, n = 11), chronic hypersensitivity pneumonitis (cHP, n = 9), bronchiolitis obliterans syndrome (BOS) after prior transplantation (n = 11) and restrictive allograft syndrome (RAS) after prior transplantation (n = 14). Lungs were inflated, frozen and then scanned using CT. Four tissue cores from distinct lung regions were sampled for analysis. Disease severity was evaluated using CT and micro CT imaging. DNA was extracted from the samples and average relative telomere length (RTL) was determined using real-time qPCR.

Results: The normal lungs showed a decrease in RTL with age (p < 0.0001). Of the diseased lungs, only BOS and RAS showed significant RTL decrease with increasing lung age (p = 0.0220 and p = 0.0272 respectively). Furthermore, we found that RTL showed considerable variability between samples within both normal and diseased lungs. cHP, BOS and RAS lungs had significant shorter RTL in comparison with normal lungs, after adjustment for lung age, sex and BMI (p < 0.0001, p = 0.0051 and p = 0.0301 respectively). When investigating the relation between RTL and regional disease severity in CF, cHP and RAS, no association was found.

Conclusion: These results show a progressive decline in telomere length with age in normal, BOS and RAS lungs. cHP, BOS and RAS lungs demonstrated shorter RTL compared to normal lungs. Lung tissue RTL does not associate with regional disease severity within the lung. Therefore, tissue RTL does not seem to fully reflect peripheral blood telomere length.

Citing Articles

Beyond the Graft: Recurrence of Interstitial Lung Diseases Post Transplant.

Ntiamoah P, Mehta A J Clin Med. 2025; 14(4).

PMID: 40004625 PMC: 11857017. DOI: 10.3390/jcm14041093.


Leukocyte telomere length and attrition in association with disease severity in cystic fibrosis patients.

Martens D, Lammertyn E, Goeminne P, Colpaert K, Proesmans M, Vanaudenaerde B Aging (Albany NY). 2024; 16(16):11809-11823.

PMID: 39213174 PMC: 11386922. DOI: 10.18632/aging.206093.


Casual effects of telomere length on sarcoidosis: a bidirectional Mendelian randomization analysis.

Zhu S, Hao Z, Chen Q, Liu X, Wu W, Luo Y Front Med (Lausanne). 2024; 11:1408980.

PMID: 39086950 PMC: 11288844. DOI: 10.3389/fmed.2024.1408980.


Gene expression meta-analysis reveals aging and cellular senescence signatures in scleroderma-associated interstitial lung disease.

Yang M, Lee S, Neely J, Hinchcliff M, Wolters P, Sirota M Front Immunol. 2024; 15:1326922.

PMID: 38348044 PMC: 10859856. DOI: 10.3389/fimmu.2024.1326922.


A genomic perspective of the aging human and mouse lung with a focus on immune response and cellular senescence.

He M, Borlak J Immun Ageing. 2023; 20(1):58.

PMID: 37932771 PMC: 10626779. DOI: 10.1186/s12979-023-00373-5.


References
1.
. American Thoracic Society. Single-breath carbon monoxide diffusing capacity (transfer factor). Recommendations for a standard technique--1995 update. Am J Respir Crit Care Med. 1995; 152(6 Pt 1):2185-98. DOI: 10.1164/ajrccm.152.6.8520796. View

2.
Stanley S, Chen J, Podlevsky J, Alder J, Hansel N, Mathias R . Telomerase mutations in smokers with severe emphysema. J Clin Invest. 2015; 125(2):563-70. PMC: 4319417. DOI: 10.1172/JCI78554. View

3.
Leslie K, Cool C, Sporn T, Curran-Everett D, Steele M, Brown K . Familial idiopathic interstitial pneumonia: histopathology and survival in 30 patients. Arch Pathol Lab Med. 2012; 136(11):1366-76. DOI: 10.5858/arpa.2011-0627-OAI. View

4.
Verleden S, Vasilescu D, Willems S, Ruttens D, Vos R, Vandermeulen E . The site and nature of airway obstruction after lung transplantation. Am J Respir Crit Care Med. 2013; 189(3):292-300. DOI: 10.1164/rccm.201310-1894OC. View

5.
McDonough J, Yuan R, Suzuki M, Seyednejad N, Elliott W, Sanchez P . Small-airway obstruction and emphysema in chronic obstructive pulmonary disease. N Engl J Med. 2011; 365(17):1567-75. PMC: 3238466. DOI: 10.1056/NEJMoa1106955. View